Live
10x Genomics NewsThe Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance - simplywall.stCellThe temporal architecture of the seminiferous epithelial cycle revealed by spatial transcriptomicsCellCell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysisCellTransplanting light-dependent reactions for mammalian eye photosynthesisEndpoints NewsMakary resigns; Biogen reports Alzheimer’s data; and more10x Genomics NewsPrecision Trading with 10x Genomics Inc. (TXG) Risk Zones - Stock Traders DailyFierceBiotechTransforming neurodegenerative disease treatmentThermo FisherIs Thermo Fisher (TMO) Quietly Reinforcing Its End‑to‑End Biopharma Role With New IBTROZI Duties? - simplywall.stFierceBiotechAdvances and Opportunities in Dual Chamber InjectablesFierceBiotechAchieving Effective Manufacturing Scaleup for Clinical and Commercial SuccessFierceBiotechUtilizing AI to Facilitate Combination Product DevelopmentFierceBiotechEnsuring Sustainability Throughout Drug and Device Development

Archive

Total 11266
Page 474 / 626
Query --